Biotech Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of First-In-Class Arylepoxamide Agonist for the Treatment of Pain April 8, 2023
Biotech AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment April 8, 2023
Biotech YDS Pharmatech’s New Generative Diffusion Model Significantly Improves Structure-Based PROTAC Optimization and Ternary Interaction Analysis; Presentation at Drug Discovery Chemistry 2023 Conference April 8, 2023
Biotech Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 8, 2023
Biotech Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates November 1, 2022
Biotech REGENXBIO Presents Additional Positive Interim Data from the Phase I/II/III CAMPSIITE(TM) Trial of RGX-121 for the Treatment of MPS II (Hunter Syndrome) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium August 31, 2022
Biotech Denali Therapeutics Announces New Interim Data from Phase 1/2 Study of DNL310 (ETV:IDS) in MPS II (Hunter Syndrome) at SSIEM 2022 August 31, 2022
Search
Biotech
November 1, 2022
August 31, 2022
August 31, 2022
